Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-12

Clinical Trial Update: Sustiva Levels With Use of a Gel Capsule [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing Sustiva (efavirenz) levels when using a gel capsule formulation in people with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sustiva (efavirenz)

Snippet

Sponsor: University of Minnesota | Conditions: HIV, HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2014-09-12